STX1A and cancer: Our analysis of HRH1, NRP2, and STX1A expression using the GOBO database corroborated the overexpression of HRH1 and NRP2 in basal-like and HER2-enriched cancer subtypes, while STX1A was overexpressed only in HER2-enriched and luminal B subtypes.